Drawing for ELNORA AI

USPTO serial 98784093

ELNORA AI

Reviewed by CopyMark Law Group

Reg. 8113575Status 700Registered
Filing date
Status date
Registration date
Jan 27, 2026
Examiner
VAUSS, JERAMEY WALLACE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELNORA AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable artificial intelligence and machine learning software for data analysis, predictive modelling and transformation, workflow optimization, document generation and editing, information extraction and editing, and document collaboration and version control in research and development in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, and chemical research; Downloadable artificial intelligence software for data analysis, predictive modelling and transformation, workflow optimization, document generation and editing, information extraction and editing, and document collaboration and version control in the field of healthcare; Downloadable mobile application software for data analysis, predictive modelling and transformation, workflow optimization, document generation and editing, information extraction and editing, and document collaboration and version control in research and development in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, and chemistry; Electronic downloadable publications, namely journal articles, review articles, conference papers, protocols, research papers, letters to the editors, case studies, technical reports, books, opinion articles, short communications for use by medical professionals, academics, and researchers in the fields of science, medicine, and chemistry; Downloadable computer software for use in editing, storing, and managing data, and collaboration in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, and chemical researchACTIVE
042Scientific and technological services, namely, scientific research and analysis, in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, healthcare, and chemical research; Drug discovery services; Pharmaceutical drug development services; Software as a service (SaaS) services featuring software for use in research and development in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, and chemical research; Software as a service (SaaS) services featuring computer software platforms for use in editing, storing, and managing data, and collaboration in the fields of biotechnology, drug discovery, drug development, pharmaceutical research, and chemical research; Platform as a service (PaaS) services featuring software platforms for use in research and development in the fields of biotechnology, drug discovery, drug development, pharmaceutical research and chemical research; Research and development in the field of biotechnology; Pharmaceutical research services; Installation and maintenance services for computer and mobile application software; Computer software technical support services, namely, troubleshooting of computer software problemsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 27, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 27, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 27, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 7, 2025ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 11, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 9, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 9, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 9, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2025DOCKASSIGNED TO EXAMINER
Apr 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance